Atlas Trials

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Clinical trial NCT00288561 · COMPLETED

Trial details

NCT number
NCT00288561
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Age-Related Macular Degeneration (ARMD)
Start date
2004-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.